They probably popped Psilocybin pills
November 4, 2026 at 11:31 PM
They probably popped Psilocybin pills
In my defense: psilocybin gummy. Also dumb.
October 30, 2026 at 12:17 AM
In my defense: psilocybin gummy. Also dumb.
I wonder if anyone’s tried listening to music on psilocybin? Might be something there
November 3, 2026 at 3:34 PM
I wonder if anyone’s tried listening to music on psilocybin? Might be something there
Psilocybin collection from IKEA
November 2, 2026 at 5:00 PM
Psilocybin collection from IKEA
Every time I see one, I wonder if I've accidentally eaten some psilocybin
November 3, 2026 at 8:59 PM
Every time I see one, I wonder if I've accidentally eaten some psilocybin
Psilocybin valley, l'avall dels monguis
November 4, 2026 at 6:01 PM
Psilocybin valley, l'avall dels monguis
Psilocybin and a cookie
November 3, 2026 at 11:51 PM
Psilocybin and a cookie
(I'm reallllllllly curious about the value of the client who wanted to send us a kg or two of pure(!!!!) psilocybin)
November 2, 2026 at 8:27 PM
(I'm reallllllllly curious about the value of the client who wanted to send us a kg or two of pure(!!!!) psilocybin)
Neuroscientists from UC Berkeley, UCSF and Stanford ran parallel trials of psilocybin to see what behavioral effects were reproducible in mice. The findings challenge reported results and underscore the importance of reproducibility in psychedelic research and its potential therapeutic applications.
In parallel mouse studies, researchers fail to replicate many reported effects of psilocybin - Berkeley News
In a unique series of identical experiments, five labs dosed mice with the psychedelic drug psilocybin to see which behavioral effects are reproducible. The results were mixed, modest and temporary.
bit.ly
November 4, 2026 at 11:30 PM
Neuroscientists from UC Berkeley, UCSF and Stanford ran parallel trials of psilocybin to see what behavioral effects were reproducible in mice. The findings challenge reported results and underscore the importance of reproducibility in psychedelic research and its potential therapeutic applications.
Long suspected, finally confirmed. Next six months are going to be huge for the field of psychedelic medicine.
Two different psilocybin filings and one MDMA already under FDA review while LSD not far behind in the new year.
Two different psilocybin filings and one MDMA already under FDA review while LSD not far behind in the new year.
Usona Files Psilocybin for Depression NDA as Race With Compass Tightens
Nonprofit psychedelic research organisation Usona Institute has completed its submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) concerning its psilocybin candid...
psychedelicalpha.com
November 3, 2026 at 1:21 AM
Long suspected, finally confirmed. Next six months are going to be huge for the field of psychedelic medicine.
Two different psilocybin filings and one MDMA already under FDA review while LSD not far behind in the new year.
Two different psilocybin filings and one MDMA already under FDA review while LSD not far behind in the new year.
Lmao got served a YouTube ad for psilocybin tablets and they actually censored the words “microdose” and “mushroom.” I really don’t think anyone at YouTube actually vets ads like, at all
November 5, 2026 at 5:20 AM
Lmao got served a YouTube ad for psilocybin tablets and they actually censored the words “microdose” and “mushroom.” I really don’t think anyone at YouTube actually vets ads like, at all
Psilocybin on the Michigan ballot in 2028? Please? 🙏🥺
November 4, 2026 at 12:48 PM
Psilocybin on the Michigan ballot in 2028? Please? 🙏🥺
Our collaborative paper looking at acute and persistent effects of one dose of psilocybin in a range of mouse behavioral assays is out: rdcu.be/iiHBMSyDARWa. We learned a ton doing this with @indigenerd.bsky.social, @theborislab.bsky.social, @mazenkheirbek.bsky.social + the Lammel and Malenka labs!
rdcu.be
November 3, 2026 at 5:54 PM
Our collaborative paper looking at acute and persistent effects of one dose of psilocybin in a range of mouse behavioral assays is out: rdcu.be/iiHBMSyDARWa. We learned a ton doing this with @indigenerd.bsky.social, @theborislab.bsky.social, @mazenkheirbek.bsky.social + the Lammel and Malenka labs!
Scientists Separated Psilocybin's Brain Benefits From Its Hallucinogenic Trip
www.sciencealert.com/scientists-s...
www.sciencealert.com/scientists-s...
Scientists Separated Psilocybin's Brain Benefits From Its Hallucinogenic Trip
Psilocybin, the psychedelic compound in 'magic mushrooms', is being looked at for treatments for depression and post-traumatic stress disorder (PTSD).
www.sciencealert.com
November 2, 2026 at 2:45 PM
Scientists Separated Psilocybin's Brain Benefits From Its Hallucinogenic Trip
www.sciencealert.com/scientists-s...
www.sciencealert.com/scientists-s...
Psilocybin industry will focus on fine-tuning first-in-the-nation program in 2025 oregoncapitalchronicle.com/2024/12/13/p...
Psilocybin industry will focus on fine-tuning first-in-the-nation program in 2025 • Oregon Capital Chronicle
Advocates of psilocybin treatment say 2024 was the year when Oregon’s psychedelic program started to stand on its own.
oregoncapitalchronicle.com
November 4, 2026 at 3:13 AM
Psilocybin industry will focus on fine-tuning first-in-the-nation program in 2025 oregoncapitalchronicle.com/2024/12/13/p...
Magic pathways: the genes and enzymes of psilocybin biosynthesis
#microbiology #psilocybin #fungi #MicroSky
@asm.org
journals.asm.org/doi/10.1128/...
#microbiology #psilocybin #fungi #MicroSky
@asm.org
journals.asm.org/doi/10.1128/...
Magic pathways: the genes and enzymes of psilocybin biosynthesis | Microbiology and Molecular Biology Reviews
SUMMARYSpecies of several mushroom genera, among them Psilocybe and Inocybe, biosynthesize psilocybin, the prodrug to the powerful psychotropic and perception-altering
analog, psilocin. While “magic” ...
journals.asm.org
November 2, 2026 at 8:20 AM
Magic pathways: the genes and enzymes of psilocybin biosynthesis
#microbiology #psilocybin #fungi #MicroSky
@asm.org
journals.asm.org/doi/10.1128/...
#microbiology #psilocybin #fungi #MicroSky
@asm.org
journals.asm.org/doi/10.1128/...
Our multi-lab effort on investigating the acute and sustained effects of psilocybin on a bunch of different mouse behaviors is out!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
A multi-institutional investigation of psilocybin’s effects on mouse behavior - Nature Neuroscience
In a study across five independent labs, 2 mg kg−1 psilocybin in mice acutely increased avoidance-related behaviors in a robust, reproducible manner and acutely reduced fear expression, but previously...
www.nature.com
November 3, 2026 at 10:11 PM
Our multi-lab effort on investigating the acute and sustained effects of psilocybin on a bunch of different mouse behaviors is out!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Psychedelic Alpha reports Usona has likely filed an NDA for psilocybin in major depression, intensifying competition with #$CMPS and other developers. #$DFTX, #$HELP, #$GHRS notreload.xyz/xy/usona-psi...
Usona Psilocybin NDA Filing Intensifies Competition
Usona’s potential FDA filing for psilocybin makes the competitive landscape more real for Compass, Definium, Helus Pharma and GH Research, analyst says.
notreload.xyz
November 2, 2026 at 8:37 PM
Psychedelic Alpha reports Usona has likely filed an NDA for psilocybin in major depression, intensifying competition with #$CMPS and other developers. #$DFTX, #$HELP, #$GHRS notreload.xyz/xy/usona-psi...
The compound is unknown, it’s not psilocybin. The best known ‘shroom for causing Lilliputian hallucination is Lanmaoa asiatica.
November 5, 2026 at 3:44 AM
The compound is unknown, it’s not psilocybin. The best known ‘shroom for causing Lilliputian hallucination is Lanmaoa asiatica.
my take: old fashioned measures of spontaneous mouse behaviors and "plasticity" associated with those behaviors may have little to do with the therapeutic outcome of receiving psilocybin under clinical supervision
November 2, 2026 at 4:33 PM
my take: old fashioned measures of spontaneous mouse behaviors and "plasticity" associated with those behaviors may have little to do with the therapeutic outcome of receiving psilocybin under clinical supervision